[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Vaginal Fungi Infections Treatment Market Growth (Status and Outlook) 2023-2029

March 2023 | 100 pages | ID: GA23766F7874EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.

LPI (LP Information)' newest research report, the “Vaginal Fungi Infections Treatment Industry Forecast” looks at past sales and reviews total world Vaginal Fungi Infections Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaginal Fungi Infections Treatment sales for 2023 through 2029. With Vaginal Fungi Infections Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaginal Fungi Infections Treatment industry.

This Insight Report provides a comprehensive analysis of the global Vaginal Fungi Infections Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaginal Fungi Infections Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaginal Fungi Infections Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaginal Fungi Infections Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaginal Fungi Infections Treatment.

The global Vaginal Fungi Infections Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Vaginal Fungi Infections Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Vaginal Fungi Infections Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Vaginal Fungi Infections Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Vaginal Fungi Infections Treatment players cover Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals and PEPTONIC medical AB, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaginal Fungi Infections Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Fluconazole
  • Nystatin
  • Flucytosine
  • Others
Segmentation by application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer Inc.
  • Bausch Health Companies Inc
  • ANI Pharmaceuticals
  • Hikma Pharmaceuticals Plc
  • Lupin Limited
  • Mycovia Pharmaceuticals
  • Glenmark Pharmaceuticals Limited
  • Unique Pharmaceuticals
  • PEPTONIC medical AB
  • Aurobindo Pharma Limited
  • Dr. Reddy's Laboratories
  • SCYNEXIS
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vaginal Fungi Infections Treatment Market Size 2018-2029
  2.1.2 Vaginal Fungi Infections Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vaginal Fungi Infections Treatment Segment by Type
  2.2.1 Fluconazole
  2.2.2 Nystatin
  2.2.3 Flucytosine
  2.2.4 Others
2.3 Vaginal Fungi Infections Treatment Market Size by Type
  2.3.1 Vaginal Fungi Infections Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
2.4 Vaginal Fungi Infections Treatment Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Vaginal Fungi Infections Treatment Market Size by Application
  2.5.1 Vaginal Fungi Infections Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)

3 VAGINAL FUNGI INFECTIONS TREATMENT MARKET SIZE BY PLAYER

3.1 Vaginal Fungi Infections Treatment Market Size Market Share by Players
  3.1.1 Global Vaginal Fungi Infections Treatment Revenue by Players (2018-2023)
  3.1.2 Global Vaginal Fungi Infections Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Vaginal Fungi Infections Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VAGINAL FUNGI INFECTIONS TREATMENT BY REGIONS

4.1 Vaginal Fungi Infections Treatment Market Size by Regions (2018-2023)
4.2 Americas Vaginal Fungi Infections Treatment Market Size Growth (2018-2023)
4.3 APAC Vaginal Fungi Infections Treatment Market Size Growth (2018-2023)
4.4 Europe Vaginal Fungi Infections Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Vaginal Fungi Infections Treatment Market Size by Country (2018-2023)
5.2 Americas Vaginal Fungi Infections Treatment Market Size by Type (2018-2023)
5.3 Americas Vaginal Fungi Infections Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vaginal Fungi Infections Treatment Market Size by Region (2018-2023)
6.2 APAC Vaginal Fungi Infections Treatment Market Size by Type (2018-2023)
6.3 APAC Vaginal Fungi Infections Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Vaginal Fungi Infections Treatment by Country (2018-2023)
7.2 Europe Vaginal Fungi Infections Treatment Market Size by Type (2018-2023)
7.3 Europe Vaginal Fungi Infections Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vaginal Fungi Infections Treatment by Region (2018-2023)
8.2 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VAGINAL FUNGI INFECTIONS TREATMENT MARKET FORECAST

10.1 Global Vaginal Fungi Infections Treatment Forecast by Regions (2024-2029)
  10.1.1 Global Vaginal Fungi Infections Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas Vaginal Fungi Infections Treatment Forecast
  10.1.3 APAC Vaginal Fungi Infections Treatment Forecast
  10.1.4 Europe Vaginal Fungi Infections Treatment Forecast
  10.1.5 Middle East & Africa Vaginal Fungi Infections Treatment Forecast
10.2 Americas Vaginal Fungi Infections Treatment Forecast by Country (2024-2029)
  10.2.1 United States Vaginal Fungi Infections Treatment Market Forecast
  10.2.2 Canada Vaginal Fungi Infections Treatment Market Forecast
  10.2.3 Mexico Vaginal Fungi Infections Treatment Market Forecast
  10.2.4 Brazil Vaginal Fungi Infections Treatment Market Forecast
10.3 APAC Vaginal Fungi Infections Treatment Forecast by Region (2024-2029)
  10.3.1 China Vaginal Fungi Infections Treatment Market Forecast
  10.3.2 Japan Vaginal Fungi Infections Treatment Market Forecast
  10.3.3 Korea Vaginal Fungi Infections Treatment Market Forecast
  10.3.4 Southeast Asia Vaginal Fungi Infections Treatment Market Forecast
  10.3.5 India Vaginal Fungi Infections Treatment Market Forecast
  10.3.6 Australia Vaginal Fungi Infections Treatment Market Forecast
10.4 Europe Vaginal Fungi Infections Treatment Forecast by Country (2024-2029)
  10.4.1 Germany Vaginal Fungi Infections Treatment Market Forecast
  10.4.2 France Vaginal Fungi Infections Treatment Market Forecast
  10.4.3 UK Vaginal Fungi Infections Treatment Market Forecast
  10.4.4 Italy Vaginal Fungi Infections Treatment Market Forecast
  10.4.5 Russia Vaginal Fungi Infections Treatment Market Forecast
10.5 Middle East & Africa Vaginal Fungi Infections Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt Vaginal Fungi Infections Treatment Market Forecast
  10.5.2 South Africa Vaginal Fungi Infections Treatment Market Forecast
  10.5.3 Israel Vaginal Fungi Infections Treatment Market Forecast
  10.5.4 Turkey Vaginal Fungi Infections Treatment Market Forecast
  10.5.5 GCC Countries Vaginal Fungi Infections Treatment Market Forecast
10.6 Global Vaginal Fungi Infections Treatment Forecast by Type (2024-2029)
10.7 Global Vaginal Fungi Infections Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer Inc.
  11.1.1 Pfizer Inc. Company Information
  11.1.2 Pfizer Inc. Vaginal Fungi Infections Treatment Product Offered
  11.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Pfizer Inc. Main Business Overview
  11.1.5 Pfizer Inc. Latest Developments
11.2 Bausch Health Companies Inc
  11.2.1 Bausch Health Companies Inc Company Information
  11.2.2 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Offered
  11.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Bausch Health Companies Inc Main Business Overview
  11.2.5 Bausch Health Companies Inc Latest Developments
11.3 ANI Pharmaceuticals
  11.3.1 ANI Pharmaceuticals Company Information
  11.3.2 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Offered
  11.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 ANI Pharmaceuticals Main Business Overview
  11.3.5 ANI Pharmaceuticals Latest Developments
11.4 Hikma Pharmaceuticals Plc
  11.4.1 Hikma Pharmaceuticals Plc Company Information
  11.4.2 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Offered
  11.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Hikma Pharmaceuticals Plc Main Business Overview
  11.4.5 Hikma Pharmaceuticals Plc Latest Developments
11.5 Lupin Limited
  11.5.1 Lupin Limited Company Information
  11.5.2 Lupin Limited Vaginal Fungi Infections Treatment Product Offered
  11.5.3 Lupin Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Lupin Limited Main Business Overview
  11.5.5 Lupin Limited Latest Developments
11.6 Mycovia Pharmaceuticals
  11.6.1 Mycovia Pharmaceuticals Company Information
  11.6.2 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Offered
  11.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Mycovia Pharmaceuticals Main Business Overview
  11.6.5 Mycovia Pharmaceuticals Latest Developments
11.7 Glenmark Pharmaceuticals Limited
  11.7.1 Glenmark Pharmaceuticals Limited Company Information
  11.7.2 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Offered
  11.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Glenmark Pharmaceuticals Limited Main Business Overview
  11.7.5 Glenmark Pharmaceuticals Limited Latest Developments
11.8 Unique Pharmaceuticals
  11.8.1 Unique Pharmaceuticals Company Information
  11.8.2 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Offered
  11.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Unique Pharmaceuticals Main Business Overview
  11.8.5 Unique Pharmaceuticals Latest Developments
11.9 PEPTONIC medical AB
  11.9.1 PEPTONIC medical AB Company Information
  11.9.2 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Offered
  11.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 PEPTONIC medical AB Main Business Overview
  11.9.5 PEPTONIC medical AB Latest Developments
11.10 Aurobindo Pharma Limited
  11.10.1 Aurobindo Pharma Limited Company Information
  11.10.2 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Offered
  11.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Aurobindo Pharma Limited Main Business Overview
  11.10.5 Aurobindo Pharma Limited Latest Developments
11.11 Dr. Reddy's Laboratories
  11.11.1 Dr. Reddy's Laboratories Company Information
  11.11.2 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Offered
  11.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Dr. Reddy's Laboratories Main Business Overview
  11.11.5 Dr. Reddy's Laboratories Latest Developments
11.12 SCYNEXIS
  11.12.1 SCYNEXIS Company Information
  11.12.2 SCYNEXIS Vaginal Fungi Infections Treatment Product Offered
  11.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 SCYNEXIS Main Business Overview
  11.12.5 SCYNEXIS Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Vaginal Fungi Infections Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Fluconazole
Table 3. Major Players of Nystatin
Table 4. Major Players of Flucytosine
Table 5. Major Players of Others
Table 6. Vaginal Fungi Infections Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Vaginal Fungi Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Table 9. Vaginal Fungi Infections Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Vaginal Fungi Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Vaginal Fungi Infections Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Vaginal Fungi Infections Treatment Revenue Market Share by Player (2018-2023)
Table 14. Vaginal Fungi Infections Treatment Key Players Head office and Products Offered
Table 15. Vaginal Fungi Infections Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaginal Fungi Infections Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Vaginal Fungi Infections Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Vaginal Fungi Infections Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Vaginal Fungi Infections Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Vaginal Fungi Infections Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Vaginal Fungi Infections Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Vaginal Fungi Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Vaginal Fungi Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Vaginal Fungi Infections Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Vaginal Fungi Infections Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Vaginal Fungi Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Vaginal Fungi Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Vaginal Fungi Infections Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Vaginal Fungi Infections Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Vaginal Fungi Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Vaginal Fungi Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Vaginal Fungi Infections Treatment
Table 47. Key Market Challenges & Risks of Vaginal Fungi Infections Treatment
Table 48. Key Industry Trends of Vaginal Fungi Infections Treatment
Table 49. Global Vaginal Fungi Infections Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Vaginal Fungi Infections Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Vaginal Fungi Infections Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Vaginal Fungi Infections Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Pfizer Inc. Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 54. Pfizer Inc. Vaginal Fungi Infections Treatment Product Offered
Table 55. Pfizer Inc. Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Pfizer Inc. Main Business
Table 57. Pfizer Inc. Latest Developments
Table 58. Bausch Health Companies Inc Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 59. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Offered
Table 60. Bausch Health Companies Inc Main Business
Table 61. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Bausch Health Companies Inc Latest Developments
Table 63. ANI Pharmaceuticals Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 64. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Offered
Table 65. ANI Pharmaceuticals Main Business
Table 66. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. ANI Pharmaceuticals Latest Developments
Table 68. Hikma Pharmaceuticals Plc Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 69. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Offered
Table 70. Hikma Pharmaceuticals Plc Main Business
Table 71. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Hikma Pharmaceuticals Plc Latest Developments
Table 73. Lupin Limited Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 74. Lupin Limited Vaginal Fungi Infections Treatment Product Offered
Table 75. Lupin Limited Main Business
Table 76. Lupin Limited Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Lupin Limited Latest Developments
Table 78. Mycovia Pharmaceuticals Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 79. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Offered
Table 80. Mycovia Pharmaceuticals Main Business
Table 81. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Mycovia Pharmaceuticals Latest Developments
Table 83. Glenmark Pharmaceuticals Limited Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 84. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Offered
Table 85. Glenmark Pharmaceuticals Limited Main Business
Table 86. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Glenmark Pharmaceuticals Limited Latest Developments
Table 88. Unique Pharmaceuticals Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 89. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Offered
Table 90. Unique Pharmaceuticals Main Business
Table 91. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Unique Pharmaceuticals Latest Developments
Table 93. PEPTONIC medical AB Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 94. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Offered
Table 95. PEPTONIC medical AB Main Business
Table 96. PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. PEPTONIC medical AB Latest Developments
Table 98. Aurobindo Pharma Limited Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 99. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Offered
Table 100. Aurobindo Pharma Limited Main Business
Table 101. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Aurobindo Pharma Limited Latest Developments
Table 103. Dr. Reddy's Laboratories Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 104. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Offered
Table 105. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Dr. Reddy's Laboratories Main Business
Table 107. Dr. Reddy's Laboratories Latest Developments
Table 108. SCYNEXIS Details, Company Type, Vaginal Fungi Infections Treatment Area Served and Its Competitors
Table 109. SCYNEXIS Vaginal Fungi Infections Treatment Product Offered
Table 110. SCYNEXIS Main Business
Table 111. SCYNEXIS Vaginal Fungi Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. SCYNEXIS Latest Developments

LIST OF FIGURES

Figure 1. Vaginal Fungi Infections Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaginal Fungi Infections Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Vaginal Fungi Infections Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Vaginal Fungi Infections Treatment Sales Market Share by Country/Region (2022)
Figure 8. Vaginal Fungi Infections Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Vaginal Fungi Infections Treatment Market Size Market Share by Type in 2022
Figure 10. Vaginal Fungi Infections Treatment in Hospital Pharmacies
Figure 11. Global Vaginal Fungi Infections Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Vaginal Fungi Infections Treatment in Retail Pharmacies
Figure 13. Global Vaginal Fungi Infections Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Vaginal Fungi Infections Treatment in Online Pharmacies
Figure 15. Global Vaginal Fungi Infections Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Vaginal Fungi Infections Treatment Market Size Market Share by Application in 2022
Figure 17. Global Vaginal Fungi Infections Treatment Revenue Market Share by Player in 2022
Figure 18. Global Vaginal Fungi Infections Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Vaginal Fungi Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Vaginal Fungi Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Vaginal Fungi Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Vaginal Fungi Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Vaginal Fungi Infections Treatment Value Market Share by Country in 2022
Figure 24. United States Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Vaginal Fungi Infections Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Vaginal Fungi Infections Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Vaginal Fungi Infections Treatment Market Size Market Share by Application in 2022
Figure 31. China Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Vaginal Fungi Infections Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Vaginal Fungi Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Vaginal Fungi Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Vaginal Fungi Infections Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Vaginal Fungi Infections Treatment Market Size Market Share Forecast by Application (2024-2029)


More Publications